Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases

被引:0
|
作者
Wu, Yinuo [1 ]
Ma, Biao [2 ]
Liu, Chang [2 ]
Li, Dangdang [2 ]
Sui, Guangchao [2 ]
机构
[1] Northeast Forestry Univ, Aulin Coll, Harbin 150040, Peoples R China
[2] Northeast Forestry Univ, Coll Life Sci, Harbin 150040, Peoples R China
基金
中国国家自然科学基金;
关键词
neurodegenerative diseases; phase separation and aggregation; pathology; treatment; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; AMYLOID BETA-PROTEIN; DIPEPTIDE-REPEAT PROTEINS; SPINAL MUSCULAR-ATROPHY; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; SUPEROXIDE-DISMUTASE; RNA-BINDING; MOLECULAR TWEEZERS;
D O I
10.3390/ijms251810187
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative diseases are the leading cause of human disability and immensely reduce patients' life span and quality. The diseases are characterized by the functional loss of neuronal cells and share several common pathogenic mechanisms involving the malfunction, structural distortion, or aggregation of multiple key regulatory proteins. Cellular phase separation is the formation of biomolecular condensates that regulate numerous biological processes, including neuronal development and synaptic signaling transduction. Aberrant phase separation may cause protein aggregation that is a general phenomenon in the neuronal cells of patients suffering neurodegenerative diseases. In this review, we summarize the pathological causes of common neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease, among others. We discuss the regulation of key amyloidogenic proteins with an emphasis of their aberrant phase separation and aggregation. We also introduce the approaches as potential therapeutic strategies to ameliorate neurodegenerative diseases through intervening protein aggregation. Overall, this review consolidates the research findings of phase separation and aggregation caused by misfolded proteins in a context of neurodegenerative diseases.
引用
收藏
页数:34
相关论文
共 50 条
  • [41] Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
    Calabrese, Gaetano
    Molzahn, Cristen
    Mayor, Thibault
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (07)
  • [42] Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases
    Eftekharzadeh, Bahareh
    Hyman, Bradley T.
    Wegmann, Susanne
    MECHANISMS OF AGEING AND DEVELOPMENT, 2016, 156 : 1 - 13
  • [43] Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications
    Candelise, Niccolo
    Scaricamazza, Silvia
    Salvatori, Illari
    Ferri, Alberto
    Valle, Cristiana
    Manganelli, Valeria
    Garofalo, Tina
    Sorice, Maurizio
    Misasi, Roberta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [44] Interactions of pathological proteins in neurodegenerative diseases
    Tara L. Spires-Jones
    Johannes Attems
    Dietmar Rudolf Thal
    Acta Neuropathologica, 2017, 134 : 187 - 205
  • [45] Interactions of pathological proteins in neurodegenerative diseases
    Spires-Jones, Tara L.
    Attems, Johannes
    Thal, Dietmar Rudolf
    ACTA NEUROPATHOLOGICA, 2017, 134 (02) : 187 - 205
  • [46] On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases
    Legname, Giuseppe
    Scialo, Carlo
    PRION, 2020, 14 (01) : 257 - 270
  • [47] Distribution of the iron-binding protein lactoferrin in the pathological lesions of neurodegenerative diseases
    Leveugle, B
    Spik, G
    Perl, DP
    Bouras, C
    Fillit, HM
    Hof, PR
    LACTOFERRIN - INTERACTIONS AND BIOLOGICAL FUNCTIONS: INTERACTIONS AND BIOLOGICAL FUNCTIONS, 1997, 28 : 119 - 124
  • [48] The pathophysiology of neurodegenerative disease: Disturbing the balance between phase separation and irreversible aggregation
    Webber, Chelsea J.
    Lei, Shuwen
    Wolozin, Benjamin
    DANCING PROTEIN CLOUDS: INTRINSICALLY DISORDERED PROTEINS IN HEALTH AND DISEASE, PT B, 2020, 174 : 187 - 223
  • [49] Protein aggregation and neurodegenerative disease
    Christopher A Ross
    Michelle A Poirier
    Nature Medicine, 2004, 10 : S10 - S17
  • [50] Neurodegenerative aspects of protein aggregation
    Trzesniewska, K
    Brzyska, M
    Elbaum, D
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2004, 64 (01) : 41 - 52